Results 221 to 230 of about 104,547 (303)

Life‐Threatening Acute Tumor Lysis Syndrome With Multiorgan Failure Following First Cycle of Bendamustine–Rituximab in Chronic Lymphocytic Leukemia: A Case Report and Brief Review

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
Graphical timeline of the patient’s clinical course. The timeline illustrates key events in a patient with CLL who developed acute tumor lysis syndrome after the first cycle of bendamustine–rituximab, including TLS onset, multiorgan failure, hemodialysis, and full recovery. ABSTRACT Chronic lymphocytic leukemia is not uniformly low risk for tumor lysis
Malegna Temesgen Garuma   +5 more
wiley   +1 more source

Leukocyte Adhesion Deficiency in a 42‐Day‐Old Infant: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Leukocyte Adhesion Deficiency (LAD) is a rare primary immunodeficiency characterized by impaired leukocyte adhesion and migration, resulting in recurrent bacterial infections, poor wound healing, and delayed umbilical cord separation. We report a 42‐day‐old female infant who presented with recurrent skin infections and delayed cord detachment ...
Rasoul Goli   +6 more
wiley   +1 more source

Successful Haplo‐Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in a Child With Underlying Thrombocytopenia‐Absent Radius Syndrome: A Unique Case

open access: yesCancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background Thrombocytopenia‐absent radius (TAR) syndrome is a rare congenital disorder characterized by bilateral radial aplasia with preserved thumbs and early‐onset thrombocytopenia. While hematologic and skeletal abnormalities define the condition, its association with hematologic malignancies is extremely rare, with only a few reported ...
Sondus Al Sharidah   +3 more
wiley   +1 more source

Complete Response to Nivolumab‐Relatlimab Following Progression of Invasive Sinonasal Mucosal Melanoma on First‐Line Nivolumab‐Ipilimumab: A Case Report

open access: yesCancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background Mucosal melanoma (MM) is a rare and aggressive subtype of melanoma with a notably worse prognosis than cutaneous melanoma (CM) due to its occult presentation and unique molecular profile. For advanced cases, immunotherapy has improved outcomes in recent years, although more significantly for CM.
Reema Patel   +2 more
wiley   +1 more source

Iatrogenic Kaposi Sarcoma in an HIV‐Negative Patient With Immune Thrombocytopenic Purpura Treated With Rituximab and Corticosteroids: A Fatal Extracutaneous Presentation

open access: yesCancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background Kaposi sarcoma (KS) is a Kaposi sarcoma, an Human herpesvirus 8 infection–associated endothelial neoplasm that typically arises in the setting of immune deficiency. Iatrogenic KS in HIV‐negative patients treated for Immune thrombocytopenic purpura is rare, particularly in those receiving immunosuppressive therapies such as rituximab
Rami Khader   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy